Zoetis | Pasivo Circulante



Current Liabilities Cambio Fecha
AbbVie USD 38.75B 4.31B 2024-12
Align Technology USD 2.04B 25.59M 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Charles River Laboratories USD 994.1M 18.12M 2024-12
Dentsply International USD 1.59B 47M 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Henry Schein USD 2.8B 126M 2024-12
Idexx Laboratories USD 1.07B 58.69M 2024-12
Illumina USD 1.55B 572M 2024-12
IQVIA Holdings USD 6.96B 35M 2024-12
J&J USD 50.32B 1.44B 2024-12
Laboratory Of America USD 3.33B 81.8M 2024-12
Merck USD 28.42B 1.17B 2024-12
Neogen USD 141.2M 9.99M 2025-02
Pacira USD 309.92M 3.52M 2024-12
Patterson Companies USD 1.31B 39.02M 2025-01
Perrigo USD 1.04B 406.3M 2024-12
Pfizer USD 43B 216M 2024-12
Quest Diagnostics USD 2.17B 77M 2024-12
Sanofi 30.03B 5.82B 2024-06
Sanofi 29.16B 865M 2024-12
Zoetis USD 3.41B 1.71B 2024-12



Zoetis Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.